Julieann Sludden

Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter.

Jane A. Plumb, Gordon Strathdee, Julieann Sludden et al. · PubMed · 2000 · 488 citations

Medicine, Cancer Biology, Oncology +16

Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer

Yvette Drew, Jonathan A. Ledermann, Geoff Hall et al. · British Journal of Cancer · 2016 · 163 citations · Full text

Medicine, Oncology, Pharmacology +17

Polymeric Chitosan-based Vesicles for Drug Delivery

Ijeoma F. Uchegbu, Andreas G. Schätzlein, Laurence Tetley et al. · Journal of Pharmacy and Pharmacology · 1998 · 135 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects

Susan A. Ridge, Julieann Sludden, Oliver E. Brown et al. · British Journal of Clinical Pharmacology · 1998 · 126 citations · Full text

Life Sciences, Genetics, Pharmacology +17

Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors

Ruth Plummer, Laura Vidal, Mark Lesley et al. · Clinical Cancer Research · 2009 · 111 citations · Full text

Medicine, Oncology, Pharmacology +14